ACTRN12609001018202已完成1 期
A randomised, double-blind, comparator study to assess the safety & tolerability of a single injection into the knee joint of two different doses of MSB-CAR001 combined with Hyaluronan compared to Hyaluronan alone in patients who have recently undergone an Anterior Cruciate Ligament Reconstruction.
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 40 Years（—）
- 性别
- All
入选标准
- •1.Males or females at least 18 years of age, but not older than 40;
- •2.ACL injury requiring reconstruction with bone bruising evident on preoperative Magnetic Resonance Imaging (MRI) scan at screen or within 6 months of initial ACL injury;
- •3.Have undergone unilateral ACL reconstruction surgery within six months of injury;
- •4.Clinically stable knee after reconstruction – International Knee Documentation Committee clinical knee examination at time of surgery after reconstruction to be grade normal or nearly normal;
- •5.Willing and able to undertake a standardized rehabilitation protocol as assessed by surgeon;
- •6.ACL graft used is autograft Hamstring;
- •7.Willingness to participate in follow-up for 24 months from the time of initial treatment;
- •8.Ability to understand and willingness to sign consent form;
- •9.If a female is of childbearing potential , then she must:
- •-Have a confirmed negative urine pregnancy test result at screening, before surgery and prior to the administration of the study treatment.
- •-Agree to use a medically reliable method of preventing conception for the duration of the study
- •-Male participants with partners of childbearing potential must be willing to use a medically reliable method of preventing conception for the duration of the study.
排除标准
- •1.Women who are pregnant or breast feeding or planning to become pregnant during the study;
- •2.Known sensitivities to bovine (cow), murine (mouse), chicken products and/or dimethylsulfoxide (DMSO);
- •3.Known allergies to products from birds such as feathers, eggs or poultry;
- •4.Previous allergic reaction to Hyaluronan;
- •5.Systemic or local infection at the screen visit or at the time of the study injection;
- •6.History of any autoimmune disease, such as, systemic lupus erythematosus, Addison’s disease, Crohn’s disease, or rheumatoid arthritis;
- •7.Treatment with immunosuppression therapy within 6 months prior to screen (visit 1);
- •8.Chronic (at least 7 consecutive days) of systemic corticosteroids at a dose equivalent to > 10 mg/day of prednisolone within 14 days prior to screen (Visit 1);
- •9.Acute or chronic infectious disease, including but not limited to human immunodeficiency virus (HIV);
- •10.Treatment and /or uncompleted follow-up treatment of any investigational therapy within 6 months before the procedure and /or intent to participate in any other investigational drug or cell therapy study during the 24 month follow-up period of this study;
- •11.Recipient of prior allogeneic stem cell/progenitor cell therapy;
- •12.Undergoing a simultaneous procedure to the opposite knee;
- •13.Injury is work related and covered by workers compensation;
- •14.A medical condition, serious intercurrent illness, or extenuating circumstance that, in the opinion of the investigator, would preclude participation in the study or potentially decrease survival or interfere with ambulation or rehabilitation (e.g., histories of transient ischemic attack (TIA), stroke, uncontrolled diabetes, or liver disease);
- •15.Has antibody specificities to donor Human Leukocyte Antigens (HLA);
- •16.History or current evidence of alcohol or drug abuse or is a recreational user of illicit drugs or prescription medications;
- •17.Significant damage to the collateral or posterior ligaments of the knee;
- •18.Meniscal injury requiring more than a 1/3 resection or more than a single suture to reconstruction or a reconstruction that will alter the usual ACL rehabilitation;
- •19.History of prior surgery to the study knee joint;
- •20.History of malignancy (excluding basal cell carcinoma that has been successfully excised);
- •21.Chondral lesions noted at time of surgical reconstruction greater than Grade 1a on any surfaces;
- •22.Intra-articular steroid or corticosteroid or Hyaluronan injections in preceding 3 months to the affected joint;
- •23.Diffuse synovitis at time of surgery for the ACL reconstruction;
- •24.Indwelling metal of any description which precludes MRI examination, such as but not limited to, indwelling pacemaker, cerebral aneurysm clips, or electrical indwelling device such as bone stimulator or anything that would preclude participant from undergoing screening MRI;
- •25.Not willing to return for required follow-up visits or there is a clear demonstration of likely poor compliance;
- •26.Any other medical condition that, in the judgment of the Principal Investigator/Investigators, would prohibit the patient from participating in the study.
- •27.Patient is legally or mentally incapacitated;
- •28.Prisoners or participants who are involuntarily incarcerated;
- •29.Participants who are compulsorily detained for treatment of a psychiatric disorder.
研究者
相似试验
已完成
2 期
To access the efficacy of test product for itâ??s salon fair look everyday on healthy human female subjects.CTRI/2018/02/011784Hindustan Unilever Limited73
尚未招募
不适用
Efficacy of Me-Cal in osteoporosis patients as compared to standard calcium supplementCTRI/2018/01/011309SG PHYTO PHARMA PVT LTD
已完成
不适用
Comparative study of various analgesic methods in Pediatric cardiac surgeryCTRI/2019/02/017575vrajesh kumar kodali
尚未招募
4 期
comparing the benefit of tablet PREGABALIN with tablet DULOXETINE and only tablet PREGABALIN in nerve pain in diabetes and relation with PPARG and Akt geneCTRI/2021/02/031068IVERSITY COLLEGE OF MEDICAL SCIENCES
已完成
4 期
To compare the efficacy and safety of the combined application of topical diltiazem and lignocaine gel as compared to either drugs alone in the management of anal fissuresCTRI/2008/091/000280Troikaa Pharmaceuticals Limited75